Massachusetts General Hospital's Mind, Mood, & Memory (MMM)

Massachusetts General Hospital's Mind, Mood, & Memory (MMM) logo

Volume 17   •   Number 9  •  September 2021

What You Should Know About the New Alzheimer’s Disease Medication

When the U.S. Food and Drug Administration (FDA) approved the drug aducanumab (Aduhelm) for the treatment of Alzheimer’s disease in June, the news was greeted with a considerable mix of responses—from celebratory optimism for the first new Alzheimer’s drug in nearly 20 years to frustration and vocal disagreement with the …


Issue Highlights

Enter Your Login Credentials
This setting should only be used on your home or work computer.

×